August 19, 2016, Montréal, Canada – We are very elated to announce that Vantage BioTrials has been recognized by Global Health & Pharma Magazine as Best for Phase I-IV Clinical Trial Management Services in their 2016 International Life Sciences Awards series. “This award is yet another milestone recognizing the exceptional work & quality that Vantage BioTrials has become known for within our industry.” said Vatche Bartekian, President of Vantage BioTrials.  Bartekian continued t...

March 7, 2016, Montréal, Canada – Vantage BioTrials, in conjunction with the Clinical Research Association of Canada (CRAC), has become the first Contract Research Organization (CRO) to proudly organize a unique global conference being held on May 25-26, 2016 in Montréal.  With only two months left before the conference, “Canada Talks Pharma 2016:  A New Way Forward in Clinical Trials” is the first event of its kind showcasing new innovations and ideas on how to conduct the clinical tr...

July 13, 2015, Montréal, Canada – It is with pleasure to announce that Vantage BioTrials’ President, Vatché Bartekian, has been nominated by Ernst & Young for Entrepreneur of the Year 2015 in recognition of his vision, leadership and achievement in building a successful, growing and dynamic business. “It is a great honor to be recognized by our peers, clients, colleagues and partners through this prestigious nomination.  Ernst & Young is a beacon of quality amongst the business...

April 2, 2014, Montréal, Canada – As part of Vantage BioTrials’ continued focus and dedication in providing superior clinical trial management services to the pharmaceutical industry, we are excited to launch and share with our Sponsors, industry professionals and employees our own White Paper. As part of our commitment, Vantage BioTrials’ White Paper will serve to share as an informational resource to give our readers a more detailed look at specific areas of the pharmaceutical/clinical...

July 13, 2011, Montreal, Canada – One of Vantage BioTrials’ early stage medical device sponsors (pioneering the development of cost-effective interventional medical navigation instrumentation), announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its flagship product, a Proprietary Needle Guidance System, for lung interventions. Vantage BioTrials’ Project Management and Clinical Monitoring teams were instrumental in setting up and mana...

February 23, 2011, Montréal, Canada – After 5 years of operations and growth, Vantage BioTrials has successfully concluded four client audits of their systems, SOPs and Good Clinical Practices. The audits occurred over a span of 2 months and each resulted in minor findings. All Sponsor comments, feedbacks and observations were addressed and resolved. “We always remain open to constructive feedback from our clients and dedicated to the highest expectations of quality in the delivery of our s...